在死后人类阿尔茨海默氏病脑中单个粉样β斑块水平的空间神经脂质学
Wojciech Michno1,2,3,4, Andrew Bowman5, Durga Jha1
1Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal 43180, Sweden.
ACS chemical neuroscience
|February 1, 2024
概括
这项研究揭示了阿尔茨海默病 (AD) 患者的粉样斑块周围的大脑脂质的显著变化. 这些发现突出了潜在的新脂质生物标志物,用于AD诊断和了解疾病机制.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 脂质失调与阿尔茨海默病 (AD) 病理学有关.
- 之前在小鼠模型上的研究表明,粉样β (Aβ) 斑块附近的脂质样本发生了变化.
- 缺乏对人类AD组织中神经元脂质变化的全面分析.
研究的目的:
- 为了描述人类AD脑组织中的脂质微环境.
- 在家族性AD (fAD) 中,在Aβ斑块附近改变的特定脂类物种的识别.
- 将人类的发现与AD小鼠模型的发现进行比较.
主要方法:
- 在 PSEN1 突变载体的死后人类大脑组织上利用矩阵辅助激光脱/离子化质谱成像 (MALDI-MSI).
- 采用商业飞行时间和内部开发的轨道飞行量谱系统.
- 分析的脂质变化在单个Aβ斑块周围的空间上得到解决.
主要成果:
- 在Aβ沉积物附近确定了近40种富含或耗尽的脂和脂物种.
- 在化物 (GM),化物 (HexCer,CerP,PE-Cer),硫化物 (ST),酸氨基醇 (PI),酸乙烯胺 (PE) 和酸 (PA) 中观察到的变化.
- 在人类AD组织中发现了含有酸 (AA) 的PE和PI物种的局部增加,与一些小鼠模型的发现有所不同.
结论:
- 首次证明了人类大脑脂质微环境中的Aβ斑块相关变化.
- 这些发现支持开发用于AD特征的脂质生物标志物.
- 提供对参与AD病变发生的人类特异性分子通路的见解.
相关概念视频
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


